Showing results (501-510 of 960) with videos related to
Sort By:
Pageof 96
Journal of Physical Activity & Health|February 18, 2021
The Impact of the COVID-19 Pandemic on US College Students' Physical Activity and Mental HealthOliver W A Wilson, Kelsey E Holland, Lucas D Elliott, et al.Journal of Medicinal Chemistry|November 1, 1983
Synthesis of potential anticancer agents. Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazinesC Temple, G P Wheeler, R N Comber, et al.American Journal of Obstetrics and Gynecology|December 1, 1991
Combination antibiotics and indomethacin in idiopathic preterm labor: a randomized double-blind clinical trialE R Newton, L Shields, L E Ridgway, et al.Journal of Biomechanical Engineering|July 31, 2009
Biocompatible ionic liquids: a new approach for stabilizing proteins in liquid formulationRegina M Vrikkis, Kevin J Fraser, Kyoko Fujita, et al.Heart, Lung & Circulation|October 13, 2014
Interval training versus continuous exercise in patients with coronary artery disease: a meta-analysisAdrian D Elliott, Kanchani Rajopadhyaya, David J Bentley, et al.Cellular Immunology|September 23, 1998
IL-6-deficient mice form granulomas in murine schistosomiasis that exhibit an altered B cell responseA M Blum, A Metwali, D Elliott, et al.Journal of Chromatographic Science|June 16, 2006
Validation of high-performance liquid chromatographic-mass spectrometric method for the analysis of lidocaine in human plasmaZ Chik, T D Lee, D W Holt, et al.Biochemical and Biophysical Research Communications|August 12, 1983
Peroxide oxidation of primary alcohols to aldehydes by chloroperoxidase catalysisJ Geigert, D J Dalietos, S L Neidleman, et al.European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|April 1, 1996
An apparent functional correlation between variations in amino acid residues in HLA-DR4.1 and 4.2 serological subtypes and oligonucleotide characterizationT D Lee, A Lee, S Lai, et al.Anticancer Research|November 1, 1995
The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical studyR S Kennedy, G P Konok, G Bounous, et al.Pageof 96